Vector-borne diseases (VBDs) represent a significant public health challenge in India, accounting for a considerable proportion of the country's disease burden. This article aims to provide a comprehensive review of the prevalence and management of VBDs in India, targeting healthcare professionals.
India is endemic to numerous VBDs, including malaria, dengue, chikungunya, and Japanese encephalitis. The World Health Organization (WHO) reports that India accounts for 4% of global malaria cases. Furthermore, the country has witnessed an alarming surge in dengue and chikungunya cases over the past decade.
Several factors contribute to the complexity of managing VBDs in India. These include diverse geographical and climatic conditions, high population density, and inadequate public health infrastructure. Additionally, the lack of awareness and delayed diagnosis further exacerbate the situation.
The government of India has initiated several national programs, such as the National Vector Borne Disease Control Programme (NVBDCP), to control and prevent VBDs. These initiatives focus on early diagnosis, prompt treatment, and vector control. Furthermore, community participation and inter-sectoral collaboration are crucial for the success of these programs.
Healthcare professionals play a pivotal role in managing VBDs. Their responsibilities include early detection and treatment, patient education, and participation in community-based preventive measures. They also contribute to surveillance activities, helping identify disease trends and informing public health interventions.
Despite the challenges, significant strides have been made in managing VBDs in India. However, a comprehensive, multi-pronged approach involving healthcare professionals, government bodies, and communities is necessary to further mitigate the burden of these diseases. Continued research and investment in public health infrastructure are also key to achieving this goal.
1.
Lung nodules seen in a high percentage of non-smokers
2.
Providing essential cancer care to rural communities
3.
Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women
4.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
5.
De-escalation Misses the Mark in Inflammatory Breast Cancer
1.
Adaptive Cell Therapies for Solid Tumors
2.
Mast Cell-Tumor Cell Interactions in OSCC: Genetic and microRNA Insights
3.
The Mysterious World of Petechiae: Exploring Causes and Treatments
4.
The Surprising Role of Magnesium in Digestion, Sleep and Mental Health
5.
Tumor Microenvironment Targeting: Mechanisms, Clinical Implications, and Therapeutic Advances
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
3.
Thromboprophylaxis In Medical Settings- An Update
4.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
5.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation